LFST
LifeStance Health Group, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+31/100
Last price
12.12
▼ 0.10 (0.82%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
12.15
Prev close
12.22
Day high
12.32
Day low
11.93
Volume
2.50M
Market cap
$4.61B
P/E (TTM)
93.23
52W range
4.77 – 13.56
Day trading desk
Gap from prior close
-0.58%
Prior close 12.22
VWAP
12.01
+0.92% from price
Relative volume
0.70×
Normal
Session range
13.64%
11.00 – 12.50
Position in range
75%
Near session high
ATR (14D)
0.41
3.39% of price
Prior day high
12.24
PDH
Prior day low
11.83
PDL
Bid / ask spread
—
Quote not published
Session volume
3.08M
Avg 4.40M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.93%
-0.0%
1M
-4.79%
-5.9%
3M
+15.54%
+11.0%
6M
+89.08%
+70.9%
YTD
+72.16%
+57.9%
1Y
+119.96%
+103.5%
3Y
+76.42%
-5.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LFST open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-68.57M
Net selling
Buy transactions
7
187.46K shares
Sell transactions
16
68.76M shares
Net transactions
+23
Buys less sells
Sell : buy shares
366.8 : 1
Heavily one-sided
Insider-held shares
11.74M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 11, 26 | TPG GP A, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
SELL | 18.41M | $226.26M | Indirect |
| Sep 2, 26 | PAUNOVICH VUKASIN Chief Technology Officer |
SELL | 42.07K | $541.40K | Direct |
| Aug 14, 26 | DELUCA TERESA Director |
SELL | 7.50K | $95.10K | Direct |
| Aug 13, 26 | DELUCA TERESA Director |
SELL | 20.44K | $249.99K | Direct |
| Aug 11, 26 | BURDICK KENNETH A Director |
SELL | 500.00K | $5.75M | Direct |
| Aug 10, 26 | TPG GP A, L.L.C. Beneficial Owner of more than 10% of a Class of Security |
SELL | 13.64M | $144.89M | Indirect |
| Aug 10, 26 | PAUNOVICH VUKASIN Chief Technology Officer |
SELL | 44.39K | $481.68K | Direct |
| Aug 10, 26 | MILLER LISA K Chief Operating Officer |
SELL | 47.91K | $519.85K | Direct |
| Jul 6, 26 | BURDICK KENNETH A Director |
STOCK | 45.49K | $0 | Direct |
| Jul 2, 26 | PERSONETTE SARAH Director |
STOCK | 17.75K | $0 | Direct |
| Jul 2, 26 | DELUCA TERESA Director |
STOCK | 17.75K | $0 | Direct |
| Jul 2, 26 | PALMER ERIC P. Director |
STOCK | 17.75K | $0 | Direct |
| Jul 2, 26 | BESSLER ROBERT Director |
STOCK | 17.75K | $0 | Direct |
| Jul 2, 26 | GOLTERMANN LORI Director |
STOCK | 35.49K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BESSLER ROBERT |
Director | 1.31M | Stock Award(Grant) |
BLACK DARREN M |
Director | — | Sale |
BOURDON DAVID |
Chief Executive Officer | 1.40M | Stock Award(Grant) |
BURDICK KENNETH A |
Director | 3.02M | Sale |
PANTALEONI PABLO |
Officer | — | Sale |
PARDO RYAN |
Officer and Director | 3.65M | Stock Award(Grant) |
SHUEY ERIC A |
Director | — | Sale |
SILVERSMITH PARTNERS I GP, LLC |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
SUMMIT PARTNERS, L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
TPG GP A, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security | — | Sale |
Fundamentals
Market cap$4.61B
Enterprise value$4.88B
Revenue (TTM)$1.58B
Gross profit$531.85M
EBITDA$135.00M
Net income$50.60M
EPS (TTM)$0.13
Free cash flow$172.36M
Total cash$225.94M
Total debt$474.15M
Book value / share$3.87
Shares outstanding380.15M
Float267.08M
Short % of float8.90%
Dividend yield0.00%
Beta (5Y)1.24
Valuation & profitability ratios
Trailing P/E93.23
Forward P/E28.14
PEG ratio—
Price / sales—
Price / book3.13
EV / revenue3.08
EV / EBITDA36.14
Gross margin33.56%
Operating margin7.25%
Profit margin3.19%
Return on equity3.43%
Return on assets2.32%
Debt / equity32.10
Current ratio1.38
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.42B | $1.25B | $1.06B | $859.54M | +13.9% |
| Operating revenue | $1.42B | $1.25B | $1.06B | $859.54M | +13.9% |
| Cost of revenue | $963.19M | $848.57M | $753.57M | $622.52M | +13.5% |
| Gross profit | $461.10M | $402.40M | $302.10M | $237.02M | +14.6% |
| Selling, general & admin | $382.20M | $363.06M | $410.79M | $377.99M | +5.3% |
| Total operating expense | $436.95M | $434.01M | $491.23M | $447.19M | +0.7% |
| Operating income | $24.15M | -$31.61M | -$189.13M | -$210.17M | +176.4% |
| Net interest income | -$11.66M | -$26.54M | -$21.22M | -$19.93M | +56.1% |
| Pre-tax income | $12.36M | -$57.61M | -$206.58M | -$232.73M | +121.5% |
| Tax provision | $2.70M | -$170.00K | -$20.32M | -$17.17M | +1,688.2% |
| Net income | $9.66M | -$57.44M | -$186.26M | -$215.56M | +116.8% |
| Net income to common | $9.66M | -$57.44M | -$186.26M | -$215.56M | +116.8% |
| Basic EPS | 0.03 | -0.15 | -0.51 | -0.61 | +120.0% |
| Diluted EPS | 0.02 | -0.15 | -0.51 | -0.61 | +113.3% |
| EBIT | $24.02M | -$31.08M | -$185.36M | -$212.80M | +177.3% |
| EBITDA | $78.78M | $39.87M | -$104.93M | -$143.60M | +97.6% |
| Basic shares | 386.02M | 379.15M | 367.46M | 355.28M | +1.8% |
| Diluted shares | 391.14M | 379.15M | 367.46M | 355.28M | +3.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $248.64M | $154.57M | $78.82M | $108.62M | +60.9% |
| Cash & short-term investments | $248.64M | $154.57M | $78.82M | $108.62M | +60.9% |
| Accounts receivable | $95.71M | $131.80M | $125.41M | $100.87M | -27.4% |
| Total current assets | $416.20M | $312.51M | $225.73M | $233.22M | +33.2% |
| Property, plant & equipment | $311.30M | $313.92M | $358.93M | $393.62M | -0.8% |
| Goodwill & intangibles | $1.47B | $1.48B | $1.51B | $1.54B | -0.9% |
| Total assets | $2.20B | $2.12B | $2.11B | $2.17B | +4.0% |
| Total current liabilities | $251.96M | $228.89M | $202.87M | $176.00M | +10.1% |
| Current debt | $14.50M | $7.25M | $2.92M | $2.35M | +100.0% |
| Long-term debt | $265.93M | $279.79M | $280.29M | $225.08M | -5.0% |
| Total debt | $474.52M | $485.19M | $511.04M | $476.49M | -2.2% |
| Total liabilities | $682.92M | $672.01M | $681.04M | $655.15M | +1.6% |
| Retained earnings | -$808.63M | -$818.29M | -$760.85M | -$572.64M | +1.2% |
| Shareholder equity | $1.52B | $1.45B | $1.43B | $1.52B | +5.2% |
| Working capital | $164.24M | $83.62M | $22.86M | $57.22M | +96.4% |
| Net tangible assets | $50.00M | -$37.86M | -$85.49M | -$17.51M | +232.1% |
| Shares issued | 388.32M | 382.74M | 378.73M | 375.96M | +1.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $9.66M | -$57.44M | -$186.26M | -$215.56M | — | +116.8% |
| Depreciation & amortisation | $54.75M | $70.95M | $80.44M | $69.20M | — | -22.8% |
| Stock-based compensation | $74.70M | $76.17M | $99.39M | $187.43M | — | -1.9% |
| Change in working capital | -$40.34M | -$27.37M | -$33.72M | -$16.94M | — | -47.4% |
| Operating cash flow | $146.15M | $107.26M | -$16.88M | $52.79M | — | +36.3% |
| Capital expenditure | -$36.13M | -$21.57M | -$40.52M | -$79.25M | — | -67.5% |
| Investing cash flow | -$36.13M | -$21.57M | -$60.34M | -$139.46M | — | -67.5% |
| Share buybacks | — | — | — | $0 | $0 | — |
| Financing cash flow | -$15.96M | -$9.95M | $47.43M | $47.26M | — | -60.4% |
| Free cash flow | $110.03M | $85.69M | -$57.40M | -$26.47M | — | +28.4% |
| End cash position | $248.64M | $154.57M | $78.82M | $108.62M | — | +60.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $435.35M | $403.48M | $382.19M | $363.81M | $345.31M | — | +7.9% |
| Operating revenue | $435.35M | $403.48M | $382.19M | $363.81M | $345.31M | — | +7.9% |
| Cost of revenue | $282.31M | $267.54M | $255.90M | $247.23M | $236.88M | — | +5.5% |
| Gross profit | $153.04M | $135.93M | $126.30M | $116.58M | $108.43M | — | +12.6% |
| Selling, general & admin | $108.14M | $100.33M | $94.78M | $95.61M | $97.38M | — | +7.8% |
| Total operating expense | $122.39M | $113.65M | $108.21M | $109.17M | $111.38M | — | +7.7% |
| Operating income | $30.65M | $22.28M | $18.08M | $7.41M | -$2.95M | — | +37.6% |
| Net interest income | -$2.63M | -$1.79M | -$2.88M | -$2.81M | -$2.90M | — | -46.8% |
| Pre-tax income | $27.46M | $19.76M | $15.20M | $4.57M | -$5.94M | — | +39.0% |
| Tax provision | $3.85M | $5.52M | $3.54M | $3.50M | -$2.15M | — | -30.3% |
| Net income | $23.61M | $14.24M | $11.67M | $1.08M | -$3.79M | — | +65.8% |
| Net income to common | $23.61M | $14.24M | $11.67M | $1.08M | -$3.79M | — | +65.8% |
| Basic EPS | 0.06 | 0.04 | — | 0.00 | -0.01 | 0.00 | +50.0% |
| Diluted EPS | 0.06 | 0.04 | — | 0.00 | -0.01 | 0.00 | +50.0% |
| EBIT | $30.09M | $21.55M | $18.08M | $7.39M | -$3.04M | — | +39.6% |
| EBITDA | $44.34M | $34.87M | $31.51M | $20.94M | $10.96M | — | +27.1% |
| Basic shares | 383.52M | 387.26M | — | 386.96M | 386.73M | 383.27M | -1.0% |
| Diluted shares | 387.30M | 395.08M | — | 388.89M | 386.73M | 390.67M | -2.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $225.94M | $194.80M | $248.64M | $203.90M | $188.93M | +16.0% |
| Cash & short-term investments | $225.94M | $194.80M | $248.64M | $203.90M | $188.93M | +16.0% |
| Accounts receivable | $110.96M | $122.92M | $95.71M | $121.07M | $129.48M | -9.7% |
| Total current assets | $377.97M | $355.91M | $416.20M | $360.38M | $358.85M | +6.2% |
| Property, plant & equipment | $321.70M | $312.99M | $311.30M | $308.38M | $303.76M | +2.8% |
| Goodwill & intangibles | $1.48B | $1.47B | $1.47B | $1.47B | $1.48B | +0.4% |
| Total assets | $2.18B | $2.15B | $2.20B | $2.15B | $2.15B | +1.7% |
| Total current liabilities | $274.75M | $239.73M | $251.96M | $228.56M | $242.28M | +14.6% |
| Current debt | — | — | $14.50M | — | — | — |
| Long-term debt | $258.99M | $262.46M | $265.93M | $269.39M | $272.86M | -1.3% |
| Total debt | $459.65M | $458.65M | $474.52M | $460.95M | $463.37M | +0.2% |
| Total liabilities | $704.35M | $668.47M | $682.92M | $656.23M | $672.88M | +5.4% |
| Retained earnings | -$770.77M | -$794.38M | -$808.63M | -$820.29M | -$821.37M | +3.0% |
| Shareholder equity | $1.48B | $1.48B | $1.52B | $1.49B | $1.47B | -0.0% |
| Working capital | $103.21M | $116.18M | $164.24M | $131.82M | $116.56M | -11.2% |
| Net tangible assets | -$213.00K | $5.28M | $50.00M | $18.64M | -$3.39M | -104.0% |
| Shares issued | 382.02M | 387.81M | 388.32M | 389.00M | 389.08M | -1.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $23.61M | $14.24M | $11.67M | $1.08M | -$3.79M | — | +65.8% |
| Depreciation & amortisation | $14.25M | $13.32M | $13.43M | $13.56M | $14.01M | — | +7.0% |
| Stock-based compensation | $19.75M | $15.20M | $16.70M | $18.30M | $21.12M | — | +29.9% |
| Change in working capital | $29.95M | -$20.75M | $1.84M | -$17.18M | $21.98M | — | +244.3% |
| Operating cash flow | $99.91M | $33.11M | $57.56M | $27.29M | $64.40M | — | +201.8% |
| Capital expenditure | -$11.99M | -$10.77M | -$10.91M | -$10.29M | -$7.75M | — | -11.4% |
| Investing cash flow | -$17.89M | -$13.91M | -$10.91M | -$10.29M | -$7.75M | — | -28.6% |
| Share buybacks | -$48.52M | -$49.11M | — | — | $0 | $0 | +1.2% |
| Financing cash flow | -$50.88M | -$73.04M | -$1.91M | -$2.02M | -$2.05M | — | +30.3% |
| Free cash flow | $87.92M | $22.34M | $46.65M | $17.00M | $56.64M | — | +293.5% |
| End cash position | $225.94M | $194.80M | $248.64M | $203.90M | $188.93M | — | +16.0% |
Options analytics
Put / call volume
1.72
Put-heavy session
Put / call open interest
1.15
Positioning, not flow
Max pain
12.00
-1.0% from spot
ATM implied vol
48.6%
Nearest strike to spot
Skew (10% OTM)
+6.2%
Puts bid over calls
Call volume
82
Contracts, this expiry
Put volume
141
Contracts, this expiry
Heaviest call OI
13.00
103 contracts
Heaviest put OI
12.00
413 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.08 | 0.11 | +32.4% |
| Mar 2026 | 0.06 | 0.07 | +10.4% |
| Dec 2025 | 0.05 | 0.09 | +64.3% |
| Sep 2025 | 0.04 | 0.01 | -63.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.08 | 5 | $431.60M | +18.6% |
| Next quarter | 0.09 | 5 | $438.56M | +14.7% |
| Current year | 0.36 | 5 | $1.71B | +20.0% |
| Next year | 0.43 | 5 | $1.96B | +14.5% |
Analyst targets & ownership
Mean target$14.40
High target$18.00
Low target$12.00
Implied upside18.81%
Analyst count10
ConsensusBUY
Strong buy / Buy2 / 7
Hold2
Sell / Strong sell0 / 0
Held by insiders3.07%
Held by institutions91.08%
Institutions holding403
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
11.96
+1.37% from price
SMA 20
12.39
-2.17% from price
SMA 50
12.09
+0.28% from price
SMA 100
10.70
+13.31% from price
SMA 200
8.85
+36.95% from price
EMA 12
12.13
-0.06% from price
EMA 26
12.21
-0.70% from price
EMA 50
11.89
+1.95% from price
RSI (14)
48.2
Neutral
MACD (12,26,9)
-0.08
Hist -0.06
ATR (14)
0.41
3.39% of price
Realised vol 30D
26.3%
Annualised
Bollinger upper
13.35
20, 2σ
Bollinger lower
11.43
20, 2σ
50 / 200 cross
Golden
12.09 vs 8.85
Trend bias
Above 200
+36.95%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.63
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
26.3%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-17.1%
Peak to trough
Max drawdown 5Y
-71.7%
Peak to trough
ATR 14
0.41
3.39% of price
Beta (reported)
1.24
5Y monthly, from filing
Short interest
Shares short
16.26M
Prior 11.42M
Change vs prior
+42.3%
Shorts adding
% of float
8.90%
Normal
% of shares out
4.28%
Against total outstanding
Days to cover
3.8
Liquid
Float
267.08M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Sep 10, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Sep 9, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Aug 19, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 14, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Aug 7, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 24, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 21, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 14, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 13, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jun 5, 26 | Goldman Sachs | INITIATED | Buy | Neutral |
| May 14, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-11
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-07
Corporate Changes & Voting Matters
8-K · 2026-06-04
Corporate Changes & Voting Matters
8-K · 2026-05-12
Periodic Financial Reports
10-Q · 2026-05-07
Annual Report to Shareholders
ARS · 2026-04-22
Corporate Changes & Voting Matters
8-K · 2026-03-11
Headlines
3 Stocks Under $50 We Keep Off Our Radar
StockStory · 2d ago
3 Healthcare Stocks That Concern Us
StockStory · 5d ago
Nearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
PR Newswire · 7d ago
What’s Going On With LifeStance Health Group (LFST)?
Simply Wall St. · 8d ago
LifeStance Health CTO Sells 42,067 Shares for $541,402
Motley Fool · 14d ago
LifeStance Health Group (LFST): Buy, Sell, or Hold Post Q2 Earnings?
StockStory · 15d ago
3 Low-Volatility Stocks with Open Questions
StockStory · 19d ago
LifeStance Health Group (NASDAQ:LFST): Strongest Q2 Results from the Outpatient & Specialty Care Group
StockStory · 20d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.